STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICUI
  4. [Form 4] ICU MEDICAL INC/DE Insider Trading Activity

ICU Medical CFO sells 6,381 shares at $175

After selling 6,381 shares on Sept. 1 at $175, CFO Brian Michael Bonnell still directly holds 56,062 shares.

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

ICU MEDICAL INC/DE (ICUI) reported that Chief Financial Officer Brian Michael Bonnell sold 6,381 shares of common stock on September 1, 2026, at $175.00 per share in an open-market or private transaction. After this sale, he directly holds 56,062 shares. The sale was described as involving restricted award shares and was effected under a Rule 10b5-1 trading plan adopted on June 1, 2026, with all shares sold at the exact disclosed price.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Bonnell Brian Michael
Role Chief Financial Officer
Sold 6,381 shs ($1.12M)
Type Security Shares Price Value
Sale Common Stock F1, F2 6,381 $175.00 $1.12M
Holdings After Transaction: Common Stock — 56,062 shares (Direct)
Footnotes (2)
  1. F1. The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
  2. F2. All shares sold were sold at the exact price disclosed.
Shares sold 6,381 shares Common stock sale on September 1, 2026
Sale price per share $175.00 per share Price for all shares sold in the September 1, 2026 transaction
Shares owned after transaction 56,062 shares Direct beneficial ownership following the reported sale
Net shares sold 6,381 shares Net sell direction in transaction summary
Rule 10b5-1 plan adoption date June 1, 2026 Date the CFO adopted the trading plan used for the sale
Rule 10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted award financial
"The restricted award sales reported in this Form 4 were effected"
open market or private transaction financial
"transaction code description: Sale in open market or private transaction"

FAQ

What insider transaction did ICUI disclose in this Form 4?
ICU Medical disclosed that its CFO, Brian Michael Bonnell, sold 6,381 shares of common stock on September 1, 2026, in a transaction reported with code “S,” indicating a sale in an open market or private transaction at $175.00 per share.

How many ICUI shares does the CFO hold after this transaction?
After the reported sale, CFO Brian Michael Bonnell directly holds 56,062 shares of ICU Medical common stock. This post-transaction holding figure is disclosed in the Form 4 as the total shares beneficially owned following the transaction.

What was the sale price in the ICUI CFO’s Form 4 transaction?
The Form 4 reports that all 6,381 shares were sold at $175.00 per share. A footnote states that all shares sold were sold at the exact price disclosed, confirming that $175.00 is the per-share sale price for the entire transaction.

Was the ICUI CFO’s stock sale under a Rule 10b5-1 trading plan?
Yes. A footnote explains that the restricted award sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. The filing’s Rule 10b5-1 checkbox is also marked as affirmed.

What type of ICUI security was involved in this Form 4 transaction?
The transaction involved Common Stock of ICU Medical. The Form 4 lists the security title as common stock and reports a single non-derivative transaction with no associated derivative securities in the derivative holdings summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bonnell Brian Michael
(Last)(First)(Middle)
951 CALLE AMANECER
(Street)
SAN CLEMENTE CALIFORNIA 92673
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026S6,381(1)D$175(2)56,062D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
2. All shares sold were sold at the exact price disclosed.
By: Paula Darbyshire, Attorney-in-Fact For: Brian Bonnell09/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR